Swedencare AB (SWDCF)
2.30
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Swedencare Shareholders Equity (Quarterly) : 733.43M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 733.43M |
| March 31, 2026 | 727.72M |
| December 31, 2025 | 722.98M |
| September 30, 2025 | 726.96M |
| June 30, 2025 | 726.40M |
| March 31, 2025 | 724.60M |
| December 31, 2024 | 726.94M |
| September 30, 2024 | 723.41M |
| June 30, 2024 | 725.30M |
| March 31, 2024 | 724.38M |
| December 31, 2023 | 715.11M |
| September 30, 2023 | 722.85M |
| June 30, 2023 | 727.72M |
| March 31, 2023 | 717.01M |
| December 31, 2022 | 716.03M |
| September 30, 2022 | 713.38M |
| June 30, 2022 | 708.68M |
| March 31, 2022 | 696.03M |
| December 31, 2021 | 267.27M |
| September 30, 2021 | 263.12M |
| June 30, 2021 | 257.88M |
| March 31, 2021 | 120.03M |
| December 31, 2020 | 111.82M |
| Date | Value |
|---|---|
| September 30, 2020 | 68.01M |
| June 30, 2020 | 28.10M |
| March 31, 2020 | 14.37M |
| December 31, 2019 | 14.03M |
| September 30, 2019 | 12.68M |
| June 30, 2019 | 12.38M |
| March 31, 2019 | 11.64M |
| December 31, 2018 | 11.08M |
| September 30, 2018 | 10.43M |
| June 30, 2018 | 9.630M |
| March 31, 2018 | 9.553M |
| December 31, 2017 | 9.063M |
| September 30, 2017 | 8.393M |
| June 30, 2017 | 7.609M |
| March 31, 2017 | 6.937M |
| December 31, 2016 | 6.241M |
| September 30, 2016 | 6.002M |
| June 30, 2016 | 5.306M |
| March 31, 2016 | 1.506M |
| December 31, 2015 | 1.562M |
| September 30, 2015 | 1.645M |
| June 30, 2015 | 1.382M |
| March 31, 2015 | 1.001M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Orexo AB | 28.03M |
| Camurus AB | 483.59M |
| Moberg Pharma AB | 68.50M |
| Infant Bacterial Therapeutics AB | 8.668M |
| AstraZeneca PLC | 47.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.027B |
| Total Liabilities (Quarterly) | 293.44M |
| Debt to Equity Ratio | 0.2481 |
| Current Ratio | 2.755 |
| Net Debt Paydown Yield | -0.36% |